GRPR and prostate carcinoma: In the present work, we explored the advantages and disadvantages of using an equimolar [99mTc]Tc-DB7+[99mTc]Tc-DT11 cocktail for targeting prostate cancer using PC-3 cells and animal models, which are known to co-express the NTS1R and the GRPR.